A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors
NCT00674947
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
BIIB015
Sponsor
Biogen